Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

A growing problem, child malnutrition costs Philippines $7 billion in a year

Child malnutrition cost the Philippines $7 billion or nearly 3 percent of its GDP in one year in terms of education spending and lost productivity, while hunger-related stunting is on the rise among children, a global aid agency said.

Read More »

Rigel’s bleeding disorder drug clears key trial

Rigel Pharmaceuticals Inc. said its experimental drug to treat a bleeding disorder met its main goal in the first of two late-stage trials.

Read More »

Carmat jumps after first implantation of its bioprosthetic artificial heart

Carmat’s shares jumped after the French company announced the first implantation of its bioprosthetic artificial heart in a final-stage clinical trial.

Read More »

Key Parkinson’s Trial Delayed Due to Feud Between a Georgetown University Scientist and The Michael J. Fox Foundation

In late 2015, Charbel Moussa, a researcher at Georgetown University Medical Center (GUMC) in Washington, announced the results of a promising Phase I clinical trial of cancer drug nilotinib in Parkinson’s disease. A second clinical trial was expected to start in October, but is currently being delayed due to a what is being dubbed a “feud” between Moussa, Georgetown, and the Michael J. Fox Foundation.

Read More »

CRO AMRI Restructures and Cuts Jobs as Result of Euticals Acquisition

Contract research organization Albany Molecular Research (AMRI), headquartered in Albany, New York, announced that it will be restructuring specific operations in the U.S. and Europe. An unspecified number of jobs will be cut as a result.

Read More »

Lung disease therapy misses primary trial goal

Drugmaker Vectura Group Plc said its asthma therapy Flutiform had not met the primary endpoint in a late-stage trial to determine its ability to treat COPD.

Read More »

Valeant is sued over Philidor ties, alleged racketeering

Valeant Pharmaceuticals International Inc. was sued by buyers of its drugs, who accused the Canadian company of racketeering by forcing them to pay exorbitant prices.

Read More »

Researchers find first U.S. bacteria with worrisome superbug genes

New Jersey researchers said they had identified perhaps the first strain of E. Coli bacteria in the United States with mobile genes that make it resistant to two types of antibiotics now considered last-line defenses against superbugs.

Read More »

Mylan to launch generic EpiPen at half the price of original

Mylan NV said it would launch the first generic version of its allergy auto-injector EpiPen at half the price of the branded product, the drugmaker’s second step in less than a week to counter a wave of criticism over the product’s high price.

Read More »

Southeast Asia needs to up its game to combat Zika: experts

The spread of the Zika virus across tropical Southeast Asia is likely to be significantly under-reported as local health authorities fail to conduct adequate screening, regional experts said.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!


Ad Right Bottom